PMC9941602_01
PMC9941602_02
PMC9941602_03
PMC9941602_04
PMC9941602_05
Study flowchart.
10.1177_24715492231157659-fig2.jpg
PMC9941602_05_10.1177_24715492231157659-fig2.jpg
fig2-24715492231157659
From the initial series of 123 patients that underwent RSA (Table 1), 29 patients died (24%) for reasons unrelated to their shoulder arthroplasty, 11 were lost to follow-up (9%), and 4 required revision surgery (3%); 1 due to infection (both glenoid and humeral component exchange), 1 due to infection and subsequent dislocation (both glenoid and humeral component exchange), and 2 due to dislocation (only glenoid component exchange) (Figure 2).